Group One Trading’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,900
Closed -$13.4K 8503
2024
Q4
$13.4K Buy
+3,900
New +$123K ﹤0.01% 5942
2022
Q3
Sell
-25,956
Closed -$920K 8372
2022
Q2
$920K Sell
25,956
-25,588
-50% -$874K ﹤0.01% 2842
2022
Q1
$2.82M Buy
51,544
+51,238
+16,744% +$3.18M ﹤0.01% 2056
2021
Q4
$20K Sell
306
-33
-10% -$3.2K ﹤0.01% 6993
2021
Q3
$48K Sell
339
-483
-59% -$61.5K ﹤0.01% 6576
2021
Q2
$108K Buy
822
+405
+97% +$50.5K ﹤0.01% 5876
2021
Q1
$71K Buy
417
+306
+276% +$64.4K ﹤0.01% 5956
2020
Q4
$23K Sell
111
-1,145
-91% -$221K ﹤0.01% 5454
2020
Q3
$242K Buy
+1,256
New +$281K ﹤0.01% 3505
2020
Q2
Sell
-500
Closed -$140K 6261
2020
Q1
$140K Sell
500
-167
-25% -$51.1K ﹤0.01% 3031
2019
Q4
$248K Buy
+667
New +$191K ﹤0.01% 3017

Other funds holding QTTB

Group One Trading's QTTB Position: Q1 2026 in Review

Group One Trading held its Q32 Bio (QTTB) position steady in Q1 2026 at 34 shares worth $218. The position accounts for ﹤0.01% of the portfolio, ranked #7391.

Group One Trading first reported a position in QTTB in Q4 2019 and has held it in 13 quarters since. The position peaked at $194K in Q2 2022. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Group One Trading held 34 shares of Q32 Bio worth $218 as of Q1 2026.
  • Group One Trading left its Q32 Bio share count unchanged in Q1 2026.
  • Q32 Bio made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7391 holding.
  • Group One Trading first reported a position in Q32 Bio in Q4 2019 and has held it in 13 quarters since.
  • Group One Trading's Q32 Bio position peaked at $194K in Q2 2022.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.